Mitochondrial signatures of infant mesenchymal stem cells predict child adiposity: The Healthy Start Study

Lauren E Gyllenhammer1, Madeline Rose Keleher2, Cheyret Wood2

  • 1University of California, Irvine.

Research Square
|May 25, 2026
PubMed

Insights

Newborn mesenchymal stem cell (MSC) gene expression and DNA methylation at birth are linked to childhood obesity risk. Early-life mitochondrial pathways in MSCs may predict future fat mass accretion.

Area of Science:

  • Genetics and Epigenetics
  • Developmental Biology
  • Metabolic Health

Background:

  • Obesity is multifactorial, with early-life factors influencing risk.
  • Mesenchymal stem cells (MSCs) are key progenitors for body composition.
  • Identifying molecular signatures at birth can inform prevention strategies.

Purpose of the Study:

  • To investigate associations between newborn MSC transcriptomic and DNA methylation profiles and childhood adiposity.
  • To explore the role of molecular pathways in early-life susceptibility to obesity.

Main Methods:

  • Analyzed transcriptomic (RNAseq) and DNA methylation (Illumina EPIC) of umbilical cord-derived MSCs from 140 mother/child dyads.
  • Measured childhood adiposity (%fat mass) using air displacement plethysmography at birth, infancy, and early childhood.
  • Utilized Geneset Enrichment Analysis and targeted methylation analysis.

Main Results:

  • 302 MSC transcripts associated with adiposity across early life (FDR<0.05).
  • Mitochondrial pathways (Complex I, fatty acid beta-oxidation, TCA cycle) downregulated in MSCs linked to higher adiposity.
  • DNA methylation in specific CpGs and the HDAC4 gene region associated with adiposity.

Conclusions:

  • Newborn MSC transcriptomic and methylation profiles are associated with adiposity development through early childhood.
  • Early-life mitochondrial signatures in MSCs may indicate biological susceptibility to increased fat mass.
  • Findings highlight the potential of molecular profiling at birth for obesity risk prediction.
Abstract